| NCT03283371 |
Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy |
https://ClinicalTrials.gov/show/NCT03283371 |
Active, not recruiting |
Biogen |
2020-01-10 |
| NCT03244345 |
Depression, Stress and Vulnerability Factors in Drug Resistant Focal Epilepsies |
https://ClinicalTrials.gov/show/NCT03244345 |
Recruiting |
Assistance Publique Hopitaux De Marseille |
2020-02-20 |
| NCT03200769 |
Study of the Efficacy of the Treatment of Sleep Apnea Syndrome by CPAP in Pharmacoresistant Epilepsy |
https://ClinicalTrials.gov/show/NCT03200769 |
Recruiting |
University Hospital, Lille |
2021-09-30 |
| NCT03138876 |
EEG Cap for Identification of Non-Convulsive Status Epilepticus |
https://ClinicalTrials.gov/show/NCT03138876 |
Completed |
Mayo Clinic |
2018-08-16 |
| NCT02648529 |
Brain Maturation in Children With Localization Related Epilepsy |
https://ClinicalTrials.gov/show/NCT02648529 |
Completed |
Hospices Civils de Lyon |
2018-12-07 |
| NCT02625090 |
An Open-label Extension Study of UCB0942 in Adult Patients With Highly Drug-resistant Focal Epilepsy |
https://ClinicalTrials.gov/show/NCT02625090 |
Active, not recruiting |
UCB Pharma |
2021-12-31 |
| NCT02107989 |
Noninvasive Pre-surgical Evaluation of Patients With Focal Epilepsy and Establishment of a Normative Imaging Database |
https://ClinicalTrials.gov/show/NCT02107989 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2026-03-30 |
| NCT02535091 |
Safety and Pharmacokinetic Study of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures |
https://ClinicalTrials.gov/show/NCT02535091 |
Active, not recruiting |
SK Life Science, Inc. |
2020-12-31 |
| NCT02465970 |
Effects of Transcranial Direct Current Stimulation (TDCS) in Drug-resistant Partial Epilepsy |
https://ClinicalTrials.gov/show/NCT02465970 |
Completed |
Rennes University Hospital |
2018-11-30 |
| NCT02458820 |
Prompt Diagnosis and Treatment of Subclinical Seizures After Cardiac Arrest |
https://ClinicalTrials.gov/show/NCT02458820 |
Completed |
Children’s Hospital of Philadelphia |
2019-01-31 |
| NCT02245061 |
Cortical Excitability Assessment Using Paired Pulses |
https://ClinicalTrials.gov/show/NCT02245061 |
Recruiting |
Hospices Civils de Lyon |
2021-09-30 |
| NCT02220114 |
Acceptability Study of a New Paediatric Form of Vigabatrin in Infants and Children With Infantile Spasms or Pharmacoresistant Partial Epilepsy |
https://ClinicalTrials.gov/show/NCT02220114 |
Completed |
Orphelia Pharma |
2016-12-31 |
| NCT02208492 |
The Effects on Cognitive Function of Levetiracetam (Keppra®) Compared to Carbamazepine (Tegretol®, Carmazepine®) as Monotherapy for Children With Partial Seizure; A Multicentric Randomized Controlled Study |
https://ClinicalTrials.gov/show/NCT02208492 |
Completed |
Yonsei University |
2013-12-31 |
| NCT02076698 |
Deep Brain Stimulation of the Anterior Nucleus of the Thalamus in Epilepsy |
https://ClinicalTrials.gov/show/NCT02076698 |
Active, not recruiting |
University Hospital, Grenoble |
2020-06-30 |
| NCT01311440 |
Modified Atkins Diet Treatment for Adults With Drug-resistant Epilepsy |
https://ClinicalTrials.gov/show/NCT01311440 |
Completed |
Oslo University Hospital |
2017-06-30 |
| NCT01866111 |
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures |
https://ClinicalTrials.gov/show/NCT01866111 |
Active, not recruiting |
SK Life Science, Inc. |
2015-07-31 |
| NCT01772654 |
Arterial Spin Labeling MRI Focal Abnormalities in Refractory Epilepsy |
https://ClinicalTrials.gov/show/NCT01772654 |
Completed |
Mayo Clinic |
2013-11-30 |
| NCT01749046 |
Remegal Fixed Dose as Adjunctive Therapy in Patients With Partial Seizures |
https://ClinicalTrials.gov/show/NCT01749046 |
Completed |
Valexfarm |
2013-10-31 |
| NCT01745952 |
Treatment of Difficult to Control Focal Epilepsy With Repetitive Transcranial Magnetic Stimulation (rTMS) |
https://ClinicalTrials.gov/show/NCT01745952 |
Completed |
Universitaire Ziekenhuizen Leuven |
2015-05-31 |
| NCT01703143 |
Pilot Study to Evaluate MR-guided Laser Ablation of Focal Lesions in Patients With Medically Refractory Partial Epilepsy |
https://ClinicalTrials.gov/show/NCT01703143 |
Completed |
Mayo Clinic |
2015-01-31 |
| NCT01527513 |
Effects of Eslicarbazepine Acetate (Esl, Bia 2-093) on Cognitive Function in Children With Partial Onset Seizures |
https://ClinicalTrials.gov/show/NCT01527513 |
Completed |
Bial - Portela C S.A. |
2012-03-31 |
| NCT01498822 |
Levetiracetam Versus Oxcarbazepine as Monotherapy to Evaluate Efficacy and Safety in Subjects With Newly or Recently Diagnosed Partial Epilepsy |
https://ClinicalTrials.gov/show/NCT01498822 |
Completed |
UCB Pharma |
2014-07-31 |
| NCT01463306 |
A 12-Month Study To Evaluate The Safety And Tolerability Of Pregabalin As Add-On Therapy In Pediatric Subjects 1 Month To 16 Years Of Age With Partial Onset Seizures And Pediatric And Adult Subjects 5 To 65 Years Of Age With Primary Generalized Tonic-Clonic Seizures |
https://ClinicalTrials.gov/show/NCT01463306 |
Completed |
Pfizer |
2019-08-22 |
| NCT01397968 |
Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures |
https://ClinicalTrials.gov/show/NCT01397968 |
Active, not recruiting |
SK Life Science, Inc. |
2013-06-30 |
| NCT01389596 |
A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years |
https://ClinicalTrials.gov/show/NCT01389596 |
Completed |
Pfizer |
2016-08-10 |
| NCT04309812 |
Transcranial Direct Current to Treat Epilepsy at Home |
https://ClinicalTrials.gov/show/NCT04309812 |
Enrolling by invitation |
Stanford University |
2021-12-31 |
| NCT03955432 |
Long-term Cardiac Monitoring in Epilepsy |
https://ClinicalTrials.gov/show/NCT03955432 |
Recruiting |
Northwell Health |
2022-03-31 |
| NCT03946618 |
Neurophysiologically Based Brain State Tracking and Modulation in Focal Epilepsy |
https://ClinicalTrials.gov/show/NCT03946618 |
Recruiting |
Mayo Clinic |
2022-04-30 |
| NCT03916848 |
Novel Network Analysis of Intracranial Stereoelectroencephalography |
https://ClinicalTrials.gov/show/NCT03916848 |
Recruiting |
Great Ormond Street Hospital for Children NHS Foundation Trust |
2021-08-31 |
| NCT03882151 |
Added Value of Automated Electrical Source Localization (EPILOG PreOp®) to Presurgical Evaluation of Refractory Epilepsy |
https://ClinicalTrials.gov/show/NCT03882151 |
Recruiting |
Cliniques universitaires Saint-Luc- Université Catholique de Louvain |
2020-06-01 |
| NCT03865771 |
Sleep Related Memory Consolidation in Children With Age Related Focal Epilepsy. |
https://ClinicalTrials.gov/show/NCT03865771 |
Recruiting |
University Hospital, Strasbourg, France |
2020-09-30 |
| NCT03796962 |
A Study to Evaluate XEN1101 as Adjunctive Therapy in Focal Epilepsy |
https://ClinicalTrials.gov/show/NCT03796962 |
Recruiting |
Xenon Pharmaceuticals Inc. |
2020-07-31 |
| NCT03738072 |
Intracerebral Electrical Stimulation and the Optimisation of Presurgical Planning in Drug-refractory Partial Epilepsy |
https://ClinicalTrials.gov/show/NCT03738072 |
Recruiting |
University Hospital, Toulouse |
2021-11-30 |
| NCT03712475 |
Pharmacokinetics of Two Formulation of Pregabalin |
https://ClinicalTrials.gov/show/NCT03712475 |
Completed |
Yung Shin Pharm. Ind. Co., Ltd. |
2018-09-16 |
| NCT03607851 |
Efficacy and Safety of Rapid Titration Protocols of Lacosamide |
https://ClinicalTrials.gov/show/NCT03607851 |
Completed |
Seoul National University Hospital |
2019-06-07 |
| NCT01262677 |
Once-A-Day Pregabalin For Partial Seizures |
https://ClinicalTrials.gov/show/NCT01262677 |
Completed |
Pfizer |
2012-07-31 |
| NCT01235403 |
Trial to Assess Optimized Dosage of Lacosamide as add-on Therapy in Patients With Partial Onset Seizure |
https://ClinicalTrials.gov/show/NCT01235403 |
Completed |
UCB Pharma |
2011-12-31 |
| NCT01190098 |
Randomized Controlled Trial to Assess Effects of Lacosamide on Sleep and Wake in Adults With Focal Epilepsy |
https://ClinicalTrials.gov/show/NCT01190098 |
Completed |
The Cleveland Clinic |
2014-11-30 |
| NCT01140867 |
Open-label, Multi-center Trial of Zonisamide as Adjunctive Therapy in Patients With Uncontrolled Partial Epilepsy |
https://ClinicalTrials.gov/show/NCT01140867 |
Completed |
Eisai Inc. |
2010-08-31 |
| NCT01091662 |
Safety & Efficacy of Eslicarbazepine Monotherapy in Sub.w/Partial Epilepsy Not Well Controlled by Current Antiepileptic |
https://ClinicalTrials.gov/show/NCT01091662 |
Completed |
Sunovion |
2012-11-30 |
| NCT01090934 |
Localizing the Epileptogenic Zone With High Resolution Electroencephalography |
https://ClinicalTrials.gov/show/NCT01090934 |
Completed |
Central Hospital, Nancy, France |
2013-10-31 |
| NCT01048255 |
Study of VX-765 in Subjects With Treatment-resistant Partial Epilepsy |
https://ClinicalTrials.gov/show/NCT01048255 |
Completed |
Vertex Pharmaceuticals Incorporated |
2010-11-30 |
| NCT00991757 |
An Open-Label Extension Study to Evaluate the Safety and Tolerability of RWJ 333369 as Adjunctive Therapy in Patients 16 Years and Older With Partial Onset Seizures. |
https://ClinicalTrials.gov/show/NCT00991757 |
Completed |
SK Life Science, Inc. |
2010-10-31 |
| NCT00988429 |
Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures |
https://ClinicalTrials.gov/show/NCT00988429 |
Active, not recruiting |
Bial - Portela C S.A. |
2012-01-12 |
| NCT00988156 |
Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children |
https://ClinicalTrials.gov/show/NCT00988156 |
Completed |
Bial - Portela C S.A. |
2012-08-20 |
| NCT00986310 |
Efficacy of Fluoxetine in Reducing Ictal Hypoventilation in Patients With Partial Epilepsy |
https://ClinicalTrials.gov/show/NCT00986310 |
Completed |
University of California, Davis |
2012-02-29 |
| NCT00957684 |
Efficacy and Safety of Eslicarbazepine Acetate as Adjunctive Therapy for Refractory Partial Seizures |
https://ClinicalTrials.gov/show/NCT00957684 |
Completed |
Bial - Portela C S.A. |
2005-11-30 |
| NCT00957372 |
Efficacy and Safety of Eslicarbazepine Acetate as Adjunctive Therapy for Refractory Partial Epilepsy |
https://ClinicalTrials.gov/show/NCT00957372 |
Completed |
Bial - Portela C S.A. |
2008-06-30 |
| NCT00957047 |
Efficacy and Safety Study of BIA 2-093 in Combination With Other Anti-Epileptic Drugs to Treat Partial Epilepsy |
https://ClinicalTrials.gov/show/NCT00957047 |
Completed |
Bial - Portela C S.A. |
2006-08-31 |
| NCT00955357 |
Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures |
https://ClinicalTrials.gov/show/NCT00955357 |
Completed |
UCB Pharma |
2013-04-30 |
| NCT00918047 |
Study of PK and Safety of OXC (Oxcarbazepine) XR (Extended Release) as Adjunctive Therapy in Pediatric Epilepsy Patients |
https://ClinicalTrials.gov/show/NCT00918047 |
Completed |
Supernus Pharmaceuticals, Inc. |
2010-07-31 |
| NCT00908349 |
Safety and Tolerability of OXC XR as Adjunctive Therapy in Subjects With Refractory Partial Epilepsy |
https://ClinicalTrials.gov/show/NCT00908349 |
Completed |
Supernus Pharmaceuticals, Inc. |
2011-11-30 |
| NCT00900237 |
Study to Evaluate Pharmacokinetics and Tolerability of Multiple Doses of Eslicarbazepine Acetate and Oxcarbazepine |
https://ClinicalTrials.gov/show/NCT00900237 |
Completed |
Bial - Portela C S.A. |
2008-12-31 |
| NCT00898560 |
Effect of Repeat Administration of Eslicarbazepine Acetate on the Pharmacokinetics of a Combined Oral Contraceptive |
https://ClinicalTrials.gov/show/NCT00898560 |
Completed |
Bial - Portela C S.A. |
2008-11-30 |
| NCT00866775 |
Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs |
https://ClinicalTrials.gov/show/NCT00866775 |
Completed |
Sunovion |
2013-05-31 |
| NCT00855738 |
A Prospective, Observational Study On The Effectiveness Of New Antiepileptic Drugs As First Bitherapy In The Daily Clinical Practice |
https://ClinicalTrials.gov/show/NCT00855738 |
Completed |
Pfizer |
2009-06-30 |
| NCT02495844 |
A Study of UCB0942 in Adult Patients With Highly Drug-resistant Focal Epilepsy |
https://ClinicalTrials.gov/show/NCT02495844 |
Completed |
UCB Pharma |
2017-02-28 |
| NCT02804230 |
MR-Guided Focused Ultrasound in the Treatment of Focal Epilepsy |
https://ClinicalTrials.gov/show/NCT02804230 |
Recruiting |
InSightec |
2022-06-30 |
| NCT03446664 |
Microburst Vagus Nerve Stimulator (VNS) Therapy Feasibility Study |
https://ClinicalTrials.gov/show/NCT03446664 |
Recruiting |
LivaNova |
2021-09-30 |
| NCT02491476 |
Recording “Fast Ripples” Using Microelectrodes During Stereo-encephalography in Patients With Drug-resistant Partial Epilepsy |
https://ClinicalTrials.gov/show/NCT02491476 |
Recruiting |
University Hospital, Toulouse |
2022-04-30 |
| NCT00772603 |
Evaluation of Efficacy and Safety of OXC XR as Adjunctive Therapy for Partial Seizures |
https://ClinicalTrials.gov/show/NCT00772603 |
Completed |
Supernus Pharmaceuticals, Inc. |
2010-04-30 |
| NCT00744731 |
An Open-Label Extension Study of the Safety and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset Seizures |
https://ClinicalTrials.gov/show/NCT00744731 |
Completed |
SK Life Science, Inc. |
2010-08-31 |
| NCT00740623 |
A Study of the Effectiveness, Safety, and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset Seizures. |
https://ClinicalTrials.gov/show/NCT00740623 |
Completed |
SK Life Science, Inc. |
2009-10-31 |
| NCT00655551 |
Safety of Intravenous Lacosamide Dose Followed by Twice Daily Oral Lacosamide in Subjects With Partial-onset Seizures |
https://ClinicalTrials.gov/show/NCT00655551 |
Completed |
UCB Pharma |
2009-09-30 |
| NCT00655486 |
Study to Assess the Long-term Safety of Oral Lacosamide in Subjects With Partial-onset Seizures |
https://ClinicalTrials.gov/show/NCT00655486 |
Completed |
UCB Pharma |
2010-06-30 |
| NCT00643500 |
Pharmacovigilance Study of Keppra. SPAIN - SKATE : Safety of Keppra as Adjunctive Therapy in Epilepsy |
https://ClinicalTrials.gov/show/NCT00643500 |
Completed |
UCB Pharma |
2003-05-31 |
| NCT00643136 |
A Study of Lyrica as Treatment for Sleep Problems in Patients With Sleep Problems and Seizures |
https://ClinicalTrials.gov/show/NCT00643136 |
Completed |
Pfizer |
NA |
| NCT00630357 |
Trial to Evaluate the Safety and Efficacy of Keppra After Conversion to Mono-therapy in Subjects With Partial Epilepsy |
https://ClinicalTrials.gov/show/NCT00630357 |
Completed |
UCB Pharma |
2004-07-31 |
| NCT00620555 |
A Phase III Open-Label Extension Study Of Gabapentin As Adjunctive Therapy In Japanese Pediatric Patients With Partial Seizures |
https://ClinicalTrials.gov/show/NCT00620555 |
Completed |
Pfizer |
2010-12-31 |
| NCT00603473 |
A Phase III Open-Label Study Of Gabapentin As Adjunctive Therapy In Japanese Pediatric Patients With Partial Seizures |
https://ClinicalTrials.gov/show/NCT00603473 |
Completed |
Pfizer |
2009-12-31 |
| NCT00552305 |
To Determine Tolerability and Efficacy of Long-term Oral Lacosamide in Patients With Partial Seizures |
https://ClinicalTrials.gov/show/NCT00552305 |
Completed |
UCB Pharma |
2010-02-28 |
| NCT00537940 |
Comparative Study Of Pregabalin And Gabapentin As Adjunctive Therapy In Subjects With Partial Seizures |
https://ClinicalTrials.gov/show/NCT00537940 |
Completed |
Pfizer |
2013-07-31 |
| NCT00522275 |
Determine Safety and Efficacy of Long-term Oral Lacosamide in Patients With Partial Seizures |
https://ClinicalTrials.gov/show/NCT00522275 |
Completed |
UCB Pharma |
2009-10-31 |
| NCT00512317 |
Open-label Extension to Protocol 1042-0600 |
https://ClinicalTrials.gov/show/NCT00512317 |
Completed |
Marinus Pharmaceuticals |
2009-12-31 |
| NCT00477295 |
A Double-blind Study to Compare the Efficacy and Safety of Zonisamide and Carbamazepine as Monotherapy, in Newly Diagnosed Partial Epilepsy |
https://ClinicalTrials.gov/show/NCT00477295 |
Completed |
Eisai Inc. |
2010-12-31 |
| NCT00465517 |
A Randomized, Controlled Trial of Ganaxolone in Adult Uncontrolled Partial-Onset Seizures |
https://ClinicalTrials.gov/show/NCT00465517 |
Completed |
Marinus Pharmaceuticals |
2008-10-31 |
| NCT00448916 |
Open-Label Extension Study Of Safety And Tolerability Of Pregabalin In Pediatric Patients With Partial-Onset Seizures |
https://ClinicalTrials.gov/show/NCT00448916 |
Completed |
Pfizer |
2013-10-31 |
| NCT00438451 |
Study on the Treatment of Elderly Patients With Older and Newer Antiepileptic Drugs |
https://ClinicalTrials.gov/show/NCT00438451 |
Completed |
Johannes Gutenberg University Mainz |
2010-07-31 |
| NCT00437281 |
Safety, Tolerability, and Pharmacokinetic Study of Pregabalin in Pediatric Patients With Partial Onset Seizures |
https://ClinicalTrials.gov/show/NCT00437281 |
Completed |
Pfizer |
2012-11-30 |
| NCT00433667 |
A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures. |
https://ClinicalTrials.gov/show/NCT00433667 |
Completed |
SK Life Science, Inc. |
2007-10-31 |
| NCT00425282 |
A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures. |
https://ClinicalTrials.gov/show/NCT00425282 |
Completed |
SK Life Science, Inc. |
2007-10-31 |
| NCT00355082 |
Conversion To Monotherapy With Lamictal Extended Release Tablets For Treatment Of Partial Epilepsy |
https://ClinicalTrials.gov/show/NCT00355082 |
Completed |
GlaxoSmithKline |
2008-11-30 |
| NCT00351611 |
Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo |
https://ClinicalTrials.gov/show/NCT00351611 |
Recruiting |
Pfizer |
2020-11-11 |
| NCT00319501 |
Efficacy and Safety of Diazepam in the Management of Refractory Epilepsy in Selected Patients Who Require Intermittent Medical Intervention for Acute Repetitive Seizures. |
https://ClinicalTrials.gov/show/NCT00319501 |
Completed |
Pfizer |
2014-07-31 |
| NCT00280696 |
A Double-blind Confirmatory Trial of Levetiracetam in Epilepsy Patients With Partial Onset Seizures |
https://ClinicalTrials.gov/show/NCT00280696 |
Completed |
UCB Pharma |
2007-11-30 |
| NCT00280059 |
Study Of The Safety And Efficacy Of Lyrica In The Treatment Of Newly Diagnosed Partial Epilepsy |
https://ClinicalTrials.gov/show/NCT00280059 |
Completed |
Pfizer |
2009-12-31 |
| NCT00275925 |
Safety and Efficacy of Oxcarbazepine Monotherapy in Adults With Partial Seizures |
https://ClinicalTrials.gov/show/NCT00275925 |
Completed |
Novartis |
NA |
| NCT00275912 |
Efficacy, Safety, and Tolerability of Oxcarbazepine Monotherapy in Children With Partial Seizures |
https://ClinicalTrials.gov/show/NCT00275912 |
Completed |
Novartis |
2007-09-28 |
| NCT00266604 |
A Study to Evaluate the Dosing, Effectiveness and Safety of Topiramate for the Treatment of Epilepsy |
https://ClinicalTrials.gov/show/NCT00266604 |
Completed |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
NA |
| NCT00245713 |
Determine Effects of Adjunctive Levetiracetam on Sleep Architecture in Adults With Partial Onset Epilepsy. |
https://ClinicalTrials.gov/show/NCT00245713 |
Completed |
UCB Pharma |
2004-11-30 |
| NCT00236886 |
Prospective Pilot Study on Metabolism and Weight Changes in Topiramate-Treated Epilepsy Patients |
https://ClinicalTrials.gov/show/NCT00236886 |
Completed |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
NA |
| NCT00236873 |
A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures. |
https://ClinicalTrials.gov/show/NCT00236873 |
Completed |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
NA |
| NCT00236860 |
A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures |
https://ClinicalTrials.gov/show/NCT00236860 |
Completed |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
NA |
| NCT00236847 |
A Study of the Efficacy and Safety of Topiramate in the Treatment of Patients With Epilepsy. |
https://ClinicalTrials.gov/show/NCT00236847 |
Completed |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
NA |
| NCT00236743 |
A Study of the Effectiveness and Safety of Topiramate in the Treatment of Children With Epilepsy |
https://ClinicalTrials.gov/show/NCT00236743 |
Completed |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
NA |
| NCT00236730 |
A Study of the Efficacy and Safety of Topiramate in the Treatment of Patients With Difficult to Control Epilepsy |
https://ClinicalTrials.gov/show/NCT00236730 |
Completed |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
NA |
| NCT00236691 |
A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures. |
https://ClinicalTrials.gov/show/NCT00236691 |
Completed |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
NA |
| NCT00231556 |
A Study on Safety and Efficacy of Two Doses of Topiramate as Monotherapy in the Treatment of Newly Diagnosed or Recurrent Epilepsy |
https://ClinicalTrials.gov/show/NCT00231556 |
Completed |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
NA |
| NCT00230698 |
A Study of the Effectiveness and Safety of Topiramate Monotherapy in Patients With Recently Diagnosed Partial-Onset Seizure |
https://ClinicalTrials.gov/show/NCT00230698 |
Completed |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
NA |
| NCT00212745 |
Pilot Trial of a Behavioral Treatment for Epilepsy |
https://ClinicalTrials.gov/show/NCT00212745 |
Completed |
Oregon Health and Science University |
2009-03-31 |
| NCT00210652 |
An Open-Label Extension Study to Evaluate the Safety and Effectiveness of RWJ 333369 in Patients With Epilepsy |
https://ClinicalTrials.gov/show/NCT00210652 |
Completed |
SK Life Science, Inc. |
2010-03-31 |
| NCT00210522 |
An Open-Label Extension Study of the Effectiveness and Safety of the Investigational Compound RWJ-333369 in Patients With Epilepsy |
https://ClinicalTrials.gov/show/NCT00210522 |
Completed |
SK Life Science, Inc. |
2010-06-30 |
| NCT00175929 |
A Study of Brivaracetam in Subjects With Partial Onset Seizures |
https://ClinicalTrials.gov/show/NCT00175929 |
Completed |
UCB Pharma |
2006-03-31 |
| NCT00175890 |
A Placebo-controlled Study of Levetiracetam In Children (1mo to 4yrs of Age) With Partial Onset Seizures. |
https://ClinicalTrials.gov/show/NCT00175890 |
Completed |
UCB Pharma |
2007-01-31 |
| NCT00160654 |
Open Label Safety and Efficacy Study of Levetiracetam in Patients With Epilepsy |
https://ClinicalTrials.gov/show/NCT00160654 |
Completed |
UCB Pharma |
2006-05-31 |
| NCT00160628 |
Open Label Safety and Efficacy Study of Levetiracetam in Korean Patients With Epilepsy |
https://ClinicalTrials.gov/show/NCT00160628 |
Completed |
UCB Pharma |
2004-10-31 |
| NCT00160615 |
Follow-up Study of L059 (Levetiracetam) in Epileptic Patients With Partial Onset Seizures by Open Label Method |
https://ClinicalTrials.gov/show/NCT00160615 |
Completed |
UCB Pharma |
2007-01-17 |
| NCT00152516 |
Long-Term, Follow-Up Study Of the Safety And Efficacy Of Levetiracetam In Children With Partial Onset Seizures |
https://ClinicalTrials.gov/show/NCT00152516 |
Completed |
UCB Pharma |
2008-06-30 |
| NCT00152503 |
Study With Subjects 18-65 Years Old With Partial Onset Seizures Who Are Currently Taking Levetiracetam |
https://ClinicalTrials.gov/show/NCT00152503 |
Completed |
UCB Pharma |
2007-01-31 |
| NCT00152451 |
Study With Seletracetam (Ucb 44212) in Adult Subjects (18 to 65 Years) With Partial Onset Seizures |
https://ClinicalTrials.gov/show/NCT00152451 |
Completed |
UCB Pharma |
2007-01-31 |
| NCT00152373 |
Double-blind, Placebo-controlled Study of Levetiracetam in Adults With POS |
https://ClinicalTrials.gov/show/NCT00152373 |
Completed |
UCB Pharma |
2005-05-31 |
| NCT00151879 |
Safety and Tolerability of Intravenous SPM 927 as Replacement for Oral SPM 927 in Subjects With Partial Seizures |
https://ClinicalTrials.gov/show/NCT00151879 |
Completed |
UCB Pharma |
2006-05-31 |
| NCT00150709 |
A Study Of The Safety And Efficacy Of Levetiracetam (Keppra®) (Ucb L059) In Children With Epilepsy |
https://ClinicalTrials.gov/show/NCT00150709 |
Completed |
UCB Pharma |
2006-01-31 |
| NCT00150293 |
Evaluation of Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures. |
https://ClinicalTrials.gov/show/NCT00150293 |
Completed |
Pfizer |
NA |
| NCT00143143 |
Pregabalin Open-Label Extension Trial in Patients With Partial Seizures |
https://ClinicalTrials.gov/show/NCT00143143 |
Completed |
Pfizer |
NA |
| NCT00141414 |
To Evaluate the Long-Term Safety of Pregabalin in Refractory Partial Epilepsy. |
https://ClinicalTrials.gov/show/NCT00141414 |
Completed |
Pfizer |
NA |
| NCT00141388 |
To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures |
https://ClinicalTrials.gov/show/NCT00141388 |
Completed |
Pfizer |
NA |
| NCT00141336 |
To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures. |
https://ClinicalTrials.gov/show/NCT00141336 |
Completed |
Pfizer |
NA |
| NCT00141245 |
To Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures. |
https://ClinicalTrials.gov/show/NCT00141245 |
Completed |
Pfizer |
NA |
| NCT00113815 |
Topiramate as Adjunctive Therapy in Infants 1-24 Months for the Control of Partial Onset Seizures |
https://ClinicalTrials.gov/show/NCT00113815 |
Completed |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
2007-06-30 |
| NCT00113165 |
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures |
https://ClinicalTrials.gov/show/NCT00113165 |
Completed |
GlaxoSmithKline |
2007-07-31 |
| NCT00105040 |
A 19-week Cognition Study of Levetiracetam in Children With Partial Onset Seizures |
https://ClinicalTrials.gov/show/NCT00105040 |
Completed |
UCB Pharma |
2007-03-31 |
| NCT00050934 |
Pediatric Epilepsy Study |
https://ClinicalTrials.gov/show/NCT00050934 |
Completed |
Novartis |
2004-06-30 |